PegBio Co., Ltd. (HKEX:2565) Filings

PegBio Co., Ltd.

Filings

FilingDateTypeFiled with
VOLUNTARY ANNOUNCEMENT SUCCESSFUL INCLUSION OF THE GROUP'S CORE PRODUCT PAIDAKANG (VISEPEGENATIDE INJECTION) INTO THE 2026 NRDLNov 15, 2026Operations updateHKEX
FORM OF PROXY FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 26, 2026Nov 11, 2026Proxy formHKEX
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGNov 11, 2026Meeting noticeHKEX
(1) PROPOSED REMOVAL OF AUDITOR (2) PROPOSED APPOINTMENT OF AUDITOR (3) PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING AND (4) NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGNov 11, 2026Meeting noticeHKEX
Next Day Disclosure ReturnNov 10, 2026Next day disclosure returnHKEX
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATENov 10, 2026FinancingHKEX
CANCELLATION OF EXTRAORDINARY GENERAL MEETING AND CANCELLATION OF BOOK CLOSURE PERIODNov 6, 2026Meeting outcomeHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026Nov 4, 2026Monthly returnHKEX
PLACING OF NEW H SHARES UNDER GENERAL MANDATENov 2, 2026FinancingHKEX
FORM OF PROXY FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 12, 2026Oct 23, 2026Proxy formHKEX
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGOct 23, 2026Meeting noticeHKEX
(1) PROPOSED REMOVAL OF AUDITOR (2) PROPOSED APPOINTMENT OF AUDITOR (3) PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING AND (4) NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGOct 23, 2026Meeting noticeHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026Oct 7, 2026Monthly returnHKEX
2026 Interim ReportSep 23, 2026Interim reportHKEX
CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERINGSep 18, 2026Other filingsHKEX
PROPOSED CHANGE OF AUDITORSep 18, 2026Management or board changeHKEX
VOLUNTARY ANNOUNCEMENT CORE PRODUCT VISEPEGENATIDE INJECTION PASSED THE PRELIMINARY REVIEW IN ACCORDANCE WITH THE 2026 NATIONAL REIMBURSEMENT DRUG LIST ADJUSTMENTJun 29, 2026Operations updateHKEX
Next Day Disclosure ReturnJun 26, 2026Next day disclosure returnHKEX
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONSJun 24, 2026List of directorsHKEX